anti-Corona vaccine will enhance its global position in the pharmaceutical industry
The Secretary-General of the Federation of Arab Hospitals, Professor Tawfiq Ahmed Khoja, confirmed that the direction of
The Kingdom of Saudi Arabia to produce a 100% Saudi vaccine against the emerging corona virus “Covid 19”, which enhances the Kingdom’s position globally in the field of drug industry and scientific research and also contributes to achieving pharmaceutical security for the Kingdom, pointing out that the challenges that the world faced due to the Corona pandemic were great and did not History has witnessed it before, which called for the movement of the countries of the world to find a vaccine that protects humanity from the fierce virus, and this has been achieved by the grace of God for many countries, and efforts are still continuing in other countries, including ours, to achieve drug security.
He pointed out that the Saudi vaccine is of great importance at the local and global levels for 3 important considerations:
⁃ Rescue and protect members of global communities from a virus that has infected 247 million people so far, and killed 5 million people in a precedent not witnessed by humanity.
⁃ The global presence in the medical arena in the field of the Corona vaccine industry and its pharmaceutical research, which enhances the Kingdom’s efforts and confirms its scientific position at all levels.
⁃ Achieving public health and national drug security by ensuring the availability of the important and vital drug for all members of society and protecting them from the virus and its multiple mutations.
He pointed out that the volume of investment in the pharmaceutical sector in the Kingdom is the largest in the region, as it exceeds 30% of the Middle East market, and the volume of growth in this sector is estimated at 5% annually, and all these indicators contribute to the development of the important pharmaceutical industry, attracting Investments, noting that the Kingdom has many advantages, including its geographical location, the presence of the appropriate environment for investment, the stability of legislation, and others.
Professor Khoja concluded by saying that the localization of the pharmaceutical industries is a top priority for the industry system, due to its importance in achieving public health and national pharmaceutical security, as the Kingdom aims to raise the rate of localization of the pharmaceutical industry from 25% currently to 50% by 2030, stressing that the volume of The Saudi market in the pharmaceutical industry is in the range of 30 billion riyals, while the number of pharmaceutical factories in Saudi Arabia is 42 facilities registered with the Food and Drug Authority, distributed between the traditional and biological pharmaceutical industries.
It is noteworthy that the Dammam Valley Company is scheduled to take over the production of the vaccine, which is currently in the third and final phase of its trial, to be available in the market soon.
It is noteworthy that Dammam Valley Company, a company owned by Imam Abdulrahman bin Faisal University, was launched on the sidelines of the Future Investment Initiative, and works in the field of biotechnology and health.
